1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow procizumab: new trials by email Literature Review of procizumab trials Research Report on procizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care. AK1967 (Invobenitug also known as Procizumab), Placebo - Shock, Cardiogenic | Phase 1 / Phase 2 | Recruiting | 4TEEN4 Pharmaceuticals GmbH | 90 | 2025-07-13 | 2026-09-14 |
| Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab) AK1967 (Procizumab), Placebo - Safety and Tolerability, Healthy Volunteers | Phase 1 | Completed | 4TEEN4 Pharmaceuticals GmbH | 24 | 2024-03-07 | 2026-02-27 |
4TEEN4 Pharmaceuticals GmbH (2)
Netherlands (2) · Armenia (1) · Belgium (1) · Czechia (1) · France (1) · Germany (1) · Poland (1) · Serbia (1) · Spain (1)
Alexandre Mebazaa, Professor (1) · David A. Morrow, MD, MPH (1)